$CLNN·8-K

Clene Inc. · May 14, 8:02 AM ET

Compare

Clene Inc. 8-K

Research Summary

AI-generated summary

Updated

Clene Inc. Amends Convertible Notes; Reports Q1 2026 Results

What Happened

  • Clene Inc. announced a Second Amendment (effective May 11, 2026) to its amended and restated senior secured convertible promissory notes originally issued December 20, 2024 (previously amended August 13, 2025). The company also furnished a press release on May 14, 2026 reporting its first quarter 2026 financial results and operating highlights for the quarter ended March 31, 2026.

Key Details

  • Second Amendment parties: Kensington Clene 2024, LLC; 4Life Research, LLC; La Scala Investments, LLC (the “Holders”).
  • New maturity date: earlier of (A) August 13, 2027, or (B) a change in control (the “Maturity Date”).
  • Payment deferral: scheduled monthly aggregate payments of $1,000,000 (principal + accrued interest), which were to start September 13, 2026, are deferred; the full outstanding principal and accrued interest will be due on the Maturity Date.
  • Related-party connections: Kensington is controlled by director Alison Mosca; Clene has license/supply agreements with 4Life; David Lisonbee (co-founder/chair of 4Life) sits on the board of Clene’s subsidiary and controls La Scala.

Why It Matters

  • The amendment pushes cash payments out and concentrates the note obligation into a single maturity payoff, improving near-term cash outflows for Clene but leaving a larger lump-sum liability due by August 13, 2027 (or earlier on change of control). Investors should note the deferred $1.0M monthly payments and the related-party nature of the note holders. The company’s Q1 2026 results and operating highlights were released separately on May 14, 2026 (see the Company’s press release filed as Exhibit 99.1).